Upgrade to SI Premium - Free Trial

Vir Biotechnology Inc. (VIR)

8.65 -0.50 (5.46%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form 4 Vir Biotechnology, Inc. For: Jun 01 Filed by: Napolitano Janet June 2, 2026 5:35 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: Jun 01 Filed by: Sabatini Brent June 2, 2026 5:32 PM - SEC Filing Form 144 Vir Biotechnology, Inc. Filed by: Sabatini Brent June 1, 2026 3:04 PM - SEC Filing Form 144 Vir Biotechnology, Inc. Filed by: Napolitano Janet June 1, 2026 1:05 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: Sigal Charles Elliott May 28, 2026 7:26 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: Napolitano Janet May 28, 2026 7:25 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: MORE ROBERT J May 28, 2026 7:25 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: Hatfield Jeffrey S. May 28, 2026 7:25 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: Farid Ramy May 28, 2026 7:24 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: May 27 Filed by: BISCHOFBERGER NORBERT W May 28, 2026 7:24 PM - SEC Filing Form 8-K Vir Biotechnology, Inc. For: May 25 May 28, 2026 9:01 AM - SEC Filing Vir Biotechnology to present hepatitis delta trial data at EASL Congress May 18, 2026 4:05 PM - StreetInsider Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026 May 18, 2026 4:05 PM - BizWire Form SCHEDULE 13G/A Vir Biotechnology, Inc. Filed by: SB INVESTMENT ADVISERS (UK) LTD May 15, 2026 9:00 PM - SEC Filing "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies May 14, 2026 11:12 AM - StreetInsider "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies May 14, 2026 10:55 AM - Globe NewsWire Vir Biotechnology (VIR) PT Lowered to $23 at Morgan Stanley May 8, 2026 8:11 AM - StreetInsider Form 10-Q Vir Biotechnology, Inc. For: Mar 31 May 7, 2026 6:01 AM - SEC Filing Form 8-K Vir Biotechnology, Inc. For: May 06 May 6, 2026 4:12 PM - SEC Filing Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 75c, offers outlook May 6, 2026 4:07 PM - StreetInsider Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results May 6, 2026 4:05 PM - BizWire Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference May 5, 2026 4:05 PM - BizWire Form 4 Vir Biotechnology, Inc. For: May 01 Filed by: SATO VICKI L May 4, 2026 12:36 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: Apr 29 Filed by: De Backer Marianne April 30, 2026 5:43 PM - SEC Filing Form 144 Vir Biotechnology, Inc. Filed by: Eisner Mark April 30, 2026 10:20 AM - SEC Filing Form SCHEDULE 13G Vir Biotechnology, Inc. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC April 29, 2026 3:50 PM - SEC Filing Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results April 23, 2026 4:05 PM - BizWire Form ARS Vir Biotechnology, Inc. For: Dec 31 April 16, 2026 4:06 PM - SEC Filing Form DEFA14A Vir Biotechnology, Inc. April 16, 2026 8:49 AM - SEC Filing Form DEF 14A Vir Biotechnology, Inc. For: Dec 31 April 16, 2026 8:47 AM - SEC Filing Vir Biotechnology closes $240 million Astellas collaboration deal April 16, 2026 8:06 AM - StreetInsider Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer April 16, 2026 8:05 AM - BizWire Vir doses first patient in VIR-5500 prostate cancer expansion study April 13, 2026 8:05 AM - StreetInsider Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer April 13, 2026 8:05 AM - BizWire Form 8-K Vir Biotechnology, Inc. For: Apr 07 April 10, 2026 4:01 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: Apr 06 Filed by: De Backer Marianne April 7, 2026 4:51 PM - SEC Filing Form 144 Vir Biotechnology, Inc. Filed by: De Backer Marianne April 6, 2026 3:24 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: Apr 01 Filed by: SATO VICKI L April 2, 2026 10:47 AM - SEC Filing Form SCHEDULE 13G/A Vir Biotechnology, Inc. Filed by: VANGUARD GROUP INC March 27, 2026 1:55 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: Mar 23 Filed by: Sabatini Brent March 24, 2026 4:36 PM - SEC Filing Form 4 Vir Biotechnology, Inc. For: Mar 20 Filed by: O'Byrne Jason March 23, 2026 3:50 PM - SEC Filing Form 144 Vir Biotechnology, Inc. Filed by: Sabatini Brent March 23, 2026 9:43 AM - SEC Filing Full Article List